Israel: A recent study published in the Journal of Diabetes and its Complications has drawn attention to the significant ...

A comprehensive first-of-its-kind national study reveals that cardiovascular-kidney-metabolic syndrome (CKM) affects nearly 4 out of 5 American adults, highlighting a health concern that has grown ...

Women who developed a cardiovascular disease or type 2 diabetes were at a higher risk of developing breast cancer post ...

Does colchicine work for CVD or doesn’t it? That’s the question the study authors hoped to answer, but there’s little ...

New research shows that signs of Alzheimer’s disease can already be detected in the blood of people as young as their 40s.

AHA comments on the U.S. Department of Health and Human Services request for information to ensure lawful regulation and unleash innovation to promote better health.

Kerendia was originally approved in July 2021 to reduce cardiovascular and kidney complications in patients with chronic ...

A Finnish population study shows that signs related to Alzheimer's disease may already be found in the brain in middle age.

Heart attack deaths are down 90%, but other serious heart conditions are on the rise. Here, cardiologists explain the findings from the AHA.

The approval was supported by data from the randomized, double-blind, placebo-controlled, event-driven phase 3 FINEARTS-HF study.

Using OCT to look at the burden, not just individual factors, helps provide clues on why disease develops—and how it ...

The drug came to AstraZeneca through its acquisition of CinCor Pharma in 2023, with the hopes of beefing up its ...